A comprehensive analysis was conducted to evaluate potential biases and diagnostic efficacy in demographic and clinicopathological characteristics, including age, gender, and tumor stage, of the Vimentin/POU4F2 combined methylation panel in urine DNA. Here, POU4F2 is linked to neoplasm.